Defensible Scope Reduction in High-Stakes Pharmaceutical IP Litigation

The legal team needed speed without sacrificing defensibility. Lineal implemented a governed, analytics-led review strategy that reduced scope before human review even started. Customized deduplication eliminated redundant content, and Amplify™ Review became the primary workflow. AI-assisted relevance assessment operated under Review Manager oversight, and every coding decision was SME-governed with documented logic. The legal team moved faster, spent less, and never had to question whether a decision would hold up.